Aemetis (NASDAQ:AMTX – Get Free Report) is expected to be announcing its earnings results before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($0.46) per share and revenue of $80.59 million for the quarter.
Aemetis Trading Down 4.0 %
Shares of Aemetis stock opened at $1.91 on Thursday. Aemetis has a 1 year low of $1.80 and a 1 year high of $7.03. The company has a market cap of $97.70 million, a P/E ratio of -0.85 and a beta of 1.44. The stock has a 50-day moving average price of $2.42 and a 200 day moving average price of $2.75.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the stock. StockNews.com raised shares of Aemetis to a “sell” rating in a research report on Wednesday, February 5th. HC Wainwright reaffirmed a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research report on Monday, December 23rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Aemetis currently has a consensus rating of “Hold” and a consensus price target of $14.56.
Aemetis Company Profile
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Featured Articles
- Five stocks we like better than Aemetis
- What Are Earnings Reports?
- Buffett’s on the Sidelines – Should You Follow?
- 3 Tickers Leading a Meme Stock Revival
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- How to Invest in Insurance Companies: A Guide
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.